On Demand 2017 Monday General Sessions
This collection covers general sessions from Monday's program. This includes plenaries, and symposia. The sessions listed below are included in this package:
- Current Approaches for Treatment of Obstructive Lung Disease
- What We Know: Non-infectious Complications of PID
- Immunology of Eczema: How to Best Address the Itch that Rashes Cause
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 4.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medical professionals who treat patients with allergic and/or immunological conditions:
- Practicing allergist/immunologists
- Allergy/immunology Fellows-in-Training
- Physician assistants
- Nurses and advanced practice nurses
- Allied health professionals
- Primary care physicians
- Other medical professionals
Upon completion of this session, participants should be able to:
- Evaluate the potential positive outcomes from GINA add-on therapy.
- Choose the patient population that will not have sufficient burden of disease to necessitate GOLD therapy.
- Evaluate all of the evidence to provide guidance for appropriate cost-effective use of these medications.
- Demonstrate competency in recognizing various forms of dermatitis that are not eczema.
- Apply treatment strategies to relieve symptoms of dermatitis.
- Prioritize different treatment strategies for the patient who itches from dermatitis.
- Describe the frequency of non-infectious complications of primary immunodeficiency.
- Recognize the manifestations of non-infectious complications of primary immunodeficiency and the appropriate evaluation of the patient.
- Be aware of the therapeutic options available for the treatment of monogeneic immunodeficiencies, including monoclonal antibodies.
- Lynda Schneider, MD, FACAAI
- Donald Y. Leung, MD, PhD, FACAAI
- Gil Yosipovitch, MD
- Luz S. Fonacier, MD, FACAAI
- Richard L. Wasserman, MD, PhD, FACAAI
- Kathleen Sullivan, MD, PhD
- Troy Torgersen, MD, PhD
- Jennifer Leiding, MD
- 4.50 AMA PRA Category 1 Credit™
- 4.50 Attendance
- 2.50 MOC